Cargando…
Comparison of the efficacy and patients’ tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials
As a new ophthalmic non-steroidal anti-inflammatory drug (NSAID) with prodrug structure, Nepafenac was supposed to have a better efficacy than conventional NSAIDs both in patients’ tolerability and ocular inflammation associated with cataract surgery. However, many current studies reached contradict...
Autores principales: | Zhao, Xinyu, Xia, Song, Wang, Erqian, Chen, Youxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333896/ https://www.ncbi.nlm.nih.gov/pubmed/28253334 http://dx.doi.org/10.1371/journal.pone.0173254 |
Ejemplares similares
-
Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: A randomized trial
por: Zanetti, Fernando Roberte, et al.
Publicado: (2012) -
Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery
por: Reddy, Rahul, et al.
Publicado: (2011) -
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
por: Singh, Rishi, et al.
Publicado: (2012) -
Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration
por: Katsev, Douglas A, et al.
Publicado: (2017) -
Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery
por: Nardi, M, et al.
Publicado: (2007)